BOSTON - September 16, 2022: Cardiovascular disease (CVD) continues to grow, with CVDs being the leading cause of death globally[1]. Nearly 18 million people died from CVDs in 2019, representing 32 percent of all global deaths and of these deaths, 85 percent were due to heart attack and stroke.[2] As a result, cardiology procedures are shifting rapidly – requiring a multi-disciplinary approach to optimize workflow, deliver better outcomes and offer patients the best treatment options.
Helping hearts: A trek across Australia to stop rheumatic heart disease in indigenous communities
Between three to five percent of Aboriginal and Torres Strait Islander Australians living in remote and regional areas suffer from rheumatic heart disease (RHD). Poverty and lack of primary healthcare is behind the persistence of a deadly disease that has been virtually absent in the rest of Australia for more than 50 years.
- Seoul National University Bundang Hospital to leverage GE Healthcare’s artificial intelligence (AI) capabilities to take the lead in using medical AI in their hospital system.
business unit
tags
- Physicians accessing GE Healthcare’s MUSE, a cardiac management system that connects to and integrates into the electronic medical record (EMR), can now view and interpret in MUSE ECGs taken by patients using AliveCor’s KardiaMobile 6L personal ECG device, strengthening the care continuum from hospital into the home, or anytime, anywhere.
- Used by 87 percent of the top cardiac hospitals in the U.S.[1], MUSE assists a physician in the analysis of an ECG based on a patient’s clinical cri
For media inquiries, please contact:
Paula Freund
Global Communications Director, Life Care Solutions
GE Healthcare
+1 414 305 1710
[email protected]
business unit
tags
Healthcare
The Heart Of An Innovative Program: These Doctors Are Working To Attract More Women To Cardiology
When Dr. Marta Sitges was in medical school at Autonomous University of Barcelona in the early 1990s, she studied alongside numerous women who were pursuing careers in medicine. Now, as director of the Cardiovascular Institute at Hospital Clínic de Barcelona, Sitges is often the only woman in the room.
“We have very few females in cardiology and, not only in this field, but in executive positions,” she says. “I haven’t felt discriminated against but, sometimes… being female, you have to demonstrate much more than being a male to reach the same positions.”
CHICAGO (June 3, 2021) - GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and participation in the ACC’s Applied Health Innovation Consortium for the purpose of building a roadmap for Artificial Intelligence (AI) and digital technology in cardiology and developing new strategies for improved health outcomes.
For media inquiries, please contact:
Holly RoloffCommunications Director
GE Healthcare
+1-414-429-6998
[email protected]
America/Chicago
business unit
tags
- The multi-year strategic partnership will enable GenesisCare to offer patients greater access to leading technology, with a plan to explore further collaborations to improve cancer diagnosis, treatment and cardiovascular care
- The agreement is valued at more than USD 130 million over the next five years, including imaging technologies, digital solutions, clinical education and services
- Together, GenesisCare and GE Healthcare aim to achieve earlier, faster and more confident cancer diagnosis and more precise intervention and individualiz
For media inquiries, please contact:
Hannah Huntly
Director, External Communications
GE Healthcare
+44 7887 824201
[email protected] Alma Dayawon
+61 4 66507548
[email protected] Bronte Kerr
Media Relations Manager
Genesis Care
+61 411 676 269
[email protected] Angharad Bhardwaj
U.S. Communications Officer
GenesisCare
843-754-2378
[email protected]
business unit
tags
